Abstract Details
|
Monica B. Dhakar, MBBS
(Xenon Pharmaceuticals)
PRESENTER |
Dr. Dhakar has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Dhakar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Dhakar has or had stock in Xenon Pharmaceuticals Inc. The institution of an immediate family member of Dr. Dhakar has received research support from NIH. The institution of an immediate family member of Dr. Dhakar has received research support from Medtronics. |
| Mahmoud Rayes, MD | No disclosure on file |
| No disclosure on file | |
| John Ko, PharmD, MS (Alnylam) | Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis. |
| Alexandros C. Tselis, MD, PhD (WSU Sch of Med/Dept of Neur Health Ctr) | No disclosure on file |
| Gregory Norris, MD (DetroitBrainInstitute) | No disclosure on file |